Fuji Pharma Co., Ltd. (4554.T)
JPY 1536.0
(0.26%)
JPY 1536.0
(0.26%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 16.51 Billion JPY | 13.43% |
| 2022 | 14.55 Billion JPY | -1.3% |
| 2021 | 14.75 Billion JPY | -0.81% |
| 2020 | 14.87 Billion JPY | -5.85% |
| 2019 | 15.79 Billion JPY | -0.97% |
| 2018 | 15.95 Billion JPY | 8.39% |
| 2017 | 14.71 Billion JPY | 8.7% |
| 2016 | 13.53 Billion JPY | 4.37% |
| 2015 | 12.97 Billion JPY | 4.77% |
| 2014 | 12.38 Billion JPY | 13.15% |
| 2013 | 10.94 Billion JPY | 17.42% |
| 2012 | 9.31 Billion JPY | -9.53% |
| 2011 | 10.29 Billion JPY | 13.44% |
| 2010 | 9.07 Billion JPY | 16.47% |
| 2009 | 7.79 Billion JPY | 20.5% |
| 2008 | 6.46 Billion JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 4.59 Billion JPY | 29.38% |
| 2024 Q1 | 3.55 Billion JPY | -28.78% |
| 2024 Q3 | 4.27 Billion JPY | -6.92% |
| 2023 Q3 | 3.9 Billion JPY | 8.69% |
| 2023 Q4 | 4.98 Billion JPY | 27.86% |
| 2023 FY | 16.51 Billion JPY | 13.43% |
| 2023 Q1 | 4.03 Billion JPY | 18.4% |
| 2023 Q2 | 3.59 Billion JPY | -11.01% |
| 2022 Q2 | 3.67 Billion JPY | -8.34% |
| 2022 Q1 | 4 Billion JPY | 10.51% |
| 2022 FY | 14.55 Billion JPY | -1.3% |
| 2022 Q4 | 3.4 Billion JPY | -1.99% |
| 2022 Q3 | 3.47 Billion JPY | -5.31% |
| 2021 Q2 | 3.62 Billion JPY | -10.06% |
| 2021 FY | 14.75 Billion JPY | -0.81% |
| 2021 Q1 | 4.03 Billion JPY | 3.59% |
| 2021 Q3 | 3.46 Billion JPY | -4.57% |
| 2021 Q4 | 3.62 Billion JPY | 4.65% |
| 2020 Q1 | 4.06 Billion JPY | 5.36% |
| 2020 FY | 14.87 Billion JPY | -5.85% |
| 2020 Q2 | 3.58 Billion JPY | -11.9% |
| 2020 Q3 | 3.32 Billion JPY | -7.14% |
| 2020 Q4 | 3.89 Billion JPY | 17.07% |
| 2019 Q4 | 3.86 Billion JPY | -3.84% |
| 2019 FY | 15.79 Billion JPY | -0.97% |
| 2019 Q1 | 4.5 Billion JPY | 10.84% |
| 2019 Q2 | 3.42 Billion JPY | -23.96% |
| 2019 Q3 | 4.01 Billion JPY | 17.3% |
| 2018 Q2 | 3.33 Billion JPY | -27.13% |
| 2018 Q1 | 4.58 Billion JPY | 17.82% |
| 2018 Q3 | 3.97 Billion JPY | 18.96% |
| 2018 Q4 | 4.06 Billion JPY | 2.24% |
| 2018 FY | 15.95 Billion JPY | 8.39% |
| 2017 FY | 14.71 Billion JPY | 8.7% |
| 2017 Q3 | 3.69 Billion JPY | 7.26% |
| 2017 Q2 | 3.44 Billion JPY | -6.74% |
| 2017 Q1 | 3.69 Billion JPY | 3.48% |
| 2017 Q4 | 3.88 Billion JPY | 5.28% |
| 2016 Q4 | 3.56 Billion JPY | 10.84% |
| 2016 FY | 13.53 Billion JPY | 4.37% |
| 2016 Q1 | 3.49 Billion JPY | 1.19% |
| 2016 Q2 | 3.25 Billion JPY | -6.89% |
| 2016 Q3 | 3.21 Billion JPY | -1.11% |
| 2015 Q3 | 3.09 Billion JPY | -2.86% |
| 2015 FY | 12.97 Billion JPY | 4.77% |
| 2015 Q1 | 3.23 Billion JPY | -8.82% |
| 2015 Q2 | 3.18 Billion JPY | -1.51% |
| 2015 Q4 | 3.45 Billion JPY | 11.63% |
| 2014 FY | 12.38 Billion JPY | 13.15% |
| 2014 Q4 | 3.54 Billion JPY | 27.63% |
| 2014 Q3 | 2.78 Billion JPY | -9.24% |
| 2014 Q2 | 3.06 Billion JPY | 2.48% |
| 2014 Q1 | 2.98 Billion JPY | -5.11% |
| 2013 Q4 | 3.15 Billion JPY | 23.67% |
| 2013 Q3 | 2.54 Billion JPY | 0.16% |
| 2013 FY | 10.94 Billion JPY | 17.42% |
| 2013 Q2 | 2.54 Billion JPY | -5.85% |
| 2013 Q1 | 2.7 Billion JPY | 0.17% |
| 2012 Q1 | 2.15 Billion JPY | -22.92% |
| 2012 Q4 | 2.69 Billion JPY | 14.57% |
| 2012 Q3 | 2.35 Billion JPY | 11.49% |
| 2012 FY | 9.31 Billion JPY | -9.53% |
| 2012 Q2 | 2.11 Billion JPY | -2.13% |
| 2011 Q4 | 2.79 Billion JPY | 11.91% |
| 2011 Q1 | 2.53 Billion JPY | 8.12% |
| 2011 FY | 10.29 Billion JPY | 13.44% |
| 2011 Q3 | 2.5 Billion JPY | 1.43% |
| 2011 Q2 | 2.46 Billion JPY | -2.8% |
| 2010 Q4 | 2.34 Billion JPY | 2.34% |
| 2010 Q2 | 2.07 Billion JPY | -12.33% |
| 2010 Q3 | 2.29 Billion JPY | 10.47% |
| 2010 Q1 | 2.36 Billion JPY | -1.88% |
| 2010 FY | 9.07 Billion JPY | 16.47% |
| 2009 Q1 | 1.74 Billion JPY | 0.0% |
| 2009 Q2 | 1.64 Billion JPY | -5.65% |
| 2009 Q3 | 1.99 Billion JPY | 21.24% |
| 2009 Q4 | 2.41 Billion JPY | 20.94% |
| 2009 FY | 7.79 Billion JPY | 20.5% |
| 2008 FY | 6.46 Billion JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 48.75 Billion JPY | 66.124% |
| Takeda Pharmaceutical Company Limited | 2184.96 Billion JPY | 99.244% |
| Sumitomo Pharma Co., Ltd. | 187.98 Billion JPY | 91.215% |
| Shionogi & Co., Ltd. | 369.08 Billion JPY | 95.525% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.54 Billion JPY | -366.414% |
| Nippon Shinyaku Co., Ltd. | 97.01 Billion JPY | 82.977% |
| Kaken Pharmaceutical Co., Ltd. | 38.22 Billion JPY | 56.792% |
| Eisai Co., Ltd. | 586.41 Billion JPY | 97.184% |
| Morishita Jintan Co., Ltd. | 5.99 Billion JPY | -175.342% |
| Hisamitsu Pharmaceutical Co., Inc. | 78.97 Billion JPY | 79.087% |
| Mochida Pharmaceutical Co., Ltd. | 52.07 Billion JPY | 68.283% |
| Fuso Pharmaceutical Industries,Ltd. | 13.51 Billion JPY | -22.179% |
| Nippon Chemiphar Co., Ltd. | 7.73 Billion JPY | -113.427% |
| Tsumura & Co. | 68.81 Billion JPY | 76.002% |
| Kissei Pharmaceutical Co., Ltd. | 37.34 Billion JPY | 55.772% |
| Torii Pharmaceutical Co., Ltd. | 24.79 Billion JPY | 33.386% |
| Towa Pharmaceutical Co., Ltd. | 81.38 Billion JPY | 79.707% |
| Zeria Pharmaceutical Co., Ltd. | 50.18 Billion JPY | 67.089% |
| KYORIN Holdings, Inc. | 51.4 Billion JPY | 67.87% |
| Taiko Pharmaceutical Co.,Ltd. | 1.07 Billion JPY | -1430.584% |
| Daito Pharmaceutical Co.,Ltd. | 9.83 Billion JPY | -67.852% |
| SymBio Pharmaceuticals Limited | 4.41 Billion JPY | -274.404% |
| MedRx Co., Ltd | 26 Million JPY | -63419.231% |
| Mizuho Medy Co.,Ltd. | 8.02 Billion JPY | -105.776% |
| Solasia Pharma K.K. | 337 Million JPY | -4800.593% |
| Modalis Therapeutics Corporation | -731 Thousand JPY | 2259333.926% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 30.66 Billion JPY | 46.144% |
| Sawai Group Holdings Co., Ltd. | 54.31 Billion JPY | 69.596% |
| Cyfuse Biomedical K.K. | 37.74 Million JPY | -43655.299% |
| Toho Holdings Co., Ltd. | 112.98 Billion JPY | 85.383% |
| Koa Shoji Holdings Co.,Ltd. | 6.63 Billion JPY | -148.735% |